Finally, a Vaccine for Cancer
From The Daily · · 22 min
This plays from the publisher's own server. We do not host a copy.
Description
An experimental vaccine has been found to prevent recurrence of melanoma. Scientists hope it won’t be the last.
A new, experimental vaccine could become the first of its kind to treat cancer.
Nina Agrawal, a health reporter for The New York Times, explains how a century-old idea is finally becoming a reality and where this breakthrough could lead next.
Guest: Nina Agrawal (https://www.nytimes.com/by/nina-agrawal), a health reporter for The New York Times.
Background reading:
- The first-of-its-kind vaccine (https://www.nytimes.com/2026/10/23/well/cancer-vaccine-melanoma-study.html) has ushered in new hope for cancer patients.
- Drug makers reported (https://www.nytimes.com/2026/10/22/well/cancer-vaccine-melanoma-merck-moderna.html) that the cancer vaccine cut the risk of melanoma recurrence.
Photo: Brendan Mcdermid/Reuters
For more information on today’s episode, visit nytimes.com/thedaily (http://nytimes.com/thedaily?smid=pc-thedaily). Transcripts of each episode will be made available by the next workday.
For more information on today’s episode, visit nytimes.com/thedaily (http://nytimes.com/thedaily?smid=pc-thedaily). Transcripts of each episode will be made available by the next workday.
Subscribe today at nytimes.com/podcasts (http://nytimes.com/podcasts) or on Apple Podcasts, Spotify and Amazon Music. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com (https://pcm.adswizz.com) for information about our collection and use of personal data for advertising.